Cargando…
Multi-center screening of the Pathogen Box collection for schistosomiasis drug discovery
BACKGROUND: Over the past five years, as a public service to encourage and accelerate drug discovery for diseases of poverty, the Medicines for Malaria Venture (MMV) has released box sets of 400 compounds named the Malaria, Pathogen and Stasis Boxes. Here, we screened the Pathogen Box against the po...
Autores principales: | Maccesi, Martina, Aguiar, Pedro H. N., Pasche, Valérian, Padilla, Melody, Suzuki, Brian M., Montefusco, Sandro, Abagyan, Ruben, Keiser, Jennifer, Mourão, Marina M., Caffrey, Conor R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805474/ https://www.ncbi.nlm.nih.gov/pubmed/31640761 http://dx.doi.org/10.1186/s13071-019-3747-6 |
Ejemplares similares
-
Screening a repurposing library, the Medicines for Malaria Venture Stasis Box, against Schistosoma mansoni
por: Pasche, Valérian, et al.
Publicado: (2018) -
Perspective
on Schistosomiasis Drug Discovery: Highlights
from a Schistosomiasis Drug Discovery Workshop at Wellcome Collection,
London, September 2022
por: Caldwell, Nicola, et al.
Publicado: (2023) -
A multi-dimensional, time-lapse, high content screening platform applied to schistosomiasis drug discovery
por: Chen, Steven, et al.
Publicado: (2020) -
Chemical and Genetic Validation of the Statin Drug Target to Treat the Helminth Disease, Schistosomiasis
por: Rojo-Arreola, Liliana, et al.
Publicado: (2014) -
Evaluation of emodepside in laboratory models of human intestinal nematode and schistosome infections
por: Karpstein, Tanja, et al.
Publicado: (2019)